Bioray Biotech Co., Ltd (TPEX: 7561)
Taiwan
· Delayed Price · Currency is TWD
21.30
0.00 (0.00%)
Dec 31, 2024, 2:21 PM CST
Bioray Biotech Revenue
Bioray Biotech had revenue of 85.80M TWD in the half year ending June 30, 2024, a decrease of -3.45%. This brings the company's revenue in the last twelve months to 183.57M, down -6.24% year-over-year. In the year 2023, Bioray Biotech had annual revenue of 191.83M with 0.65% growth.
Revenue (ttm)
183.57M
Revenue Growth
-6.24%
P/S Ratio
3.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
662.30M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Lotus Pharmaceutical | 17.59B |
Oneness Biotech | 112.20M |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |
Pegavision | 7.06B |
TaiMed Biologics | 622.61M |